Self-proteins are regularly processed for presentation to autoreactive T cells in association with both class I and class II major histocompatibility complex (MHC) molecules. The presentation of self-peptides plays a crucial role in the acquisition of T cell repertoire during thymic selection. We previously reported that the self-MHC class I peptide L a 61-80 was immunogenic in syngeneic B10.A mice (H-2~). We showed that despite its high affinity for self-MHC class II molecules, L a 61-80 peptide failed to induce elimination of autoreactive CD4 + T cells, presumably due to incomplete processing and presentation in the B10.A's developing thymus (cryptic-selfpeptide). In this report, we showed that the cryptic phenotype was not an intrinsic property of the self-peptide L a 61-80 since it was found to be naturally presented and subsequently tolerogenic in BALB/c mice (H-2 a) (dominant self-peptide). In addition, the self-peptide L a 61-80 was found to be immunogenic in different H-2 a mice while it was invariably tolerogenic in H-2 a mice regardless of their background genes. We observed that L a 61-80 bound equally well to H-2 a and H-2 k MHC class II molecules. Also, no correlation was found between the quantity of self-L a protein and the tolerogenicity ofL a 61-80. Surprisingly, L a 61-80 was not naturally presented in (H-2 a X H-2 a) F1 mice, indicating that the H-2 a MHC locus contained a gene that impaired the presentation of the self-peptide. Analyses ofT cell responses to the self-peptide in several H-2 recombinant mice revealed that the presentation ofL a 61-80 was controlled by genes that mapped to a 170-kb portion of the MHC class II region. This study shows that (a) endogenously processed self-peptides presented by MHC class II molecules are involved in shaping the CD4 + T cell repertoire in the thymus; (b) The selection of selfpeptides for presentation by MHC class II molecules to nascent autoreactive T cells is influenced by nonstructural MHC genes that map to a 170-kb portion of the MHC class II region; and (c) the MHC locus of H-2 a mice encodes factors that prevent or abrogate the presentation by MHC class II molecules of the self-peptide L a 61-80. These findings may have important implications for understanding the molecular mechanisms involved in T cell repertoire acquisition and self-tolerance induction. p rocessed foreign antigens are presented to T lymphocytes in the form ofpeptides associated with self-MHC molecules at the surface of APCs (1, 2). There is a body of evidence that demonstrates that autologous proteins are also regularly processed for presentation to self-reactive T cells in association with either class I or class II MHC molecules (3, 4). Furthermore, elution of the peptides bound to surface MHC molecules revealed that the vast majority of MHC peptide-binding grooves were filled with a variety of protein fragments of self-origin (5, 6). The self-peptides presented in the thymus during ontogeny play a key role in shaping the T cell repertoire. High affinity recognition ofself-peptide/MHC complexes by developing T cells results in their deletion/inactivation (negative selection) (7, 8) . Alternatively, T cells engaged in low avidity interaction with self-peptides presented by self-MHC presumably survive and undergo differentiation (positive selection; 9). The presentation of self-peptides is therefore an essential element in the establishment ofa T cell repertoire.
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Dissection of the different antigen processing pathways is crucial for understanding the mechanisms that govern the selection of autologous peptides for presentation to self-reactive T cells. It has become clear that determining the ability ofpeptides to bind to self-MHC molecules is neces-sary but not sufficient to predict their presentation by APCs. The set ofpeptides selected for display also depends on other factors, including the enzymatic machinery of the APC, the route of antigen processing, and the presence of several protein cofactors. Among them, the MHC-encoded proteasome subunits, LMP-2 and-7 (10, 11) , and the transporter proteins, TAP-1 and -2 (12) (13) (14) are known to be specific participants in the processing of endogenous cytosolic proteins and their presentation in peptide form by MHC class I molecules. Similarly, the invariant chain (Ii) 1 (15) , heat shock proteins (16) , and the recently described Ma and Mb gene products (17, 18) are specific cofactors in the presentation of exogenous foreign proteins by MHC class II molecules. The endogenous (class I) and exogenous (class II) antigen-processing pathways have always been considered distinct. However, considerable evidence suggesting that there is cross-talk between the two antigen processing pathways has recently been provided. Thus, endogenously synthesized proteins can also represent a source ofpeptides for class II presentation (19, 20) . Supporting this view, a large variety of peptides eluted from MHC class II molecules has been found to be derived from endogenous self-proteins (6) . Therefore, examination of the mechanisms underlying the MHC class II endogenous processing pathway may provide insight into the principals of thymic selection ofCD4 + T cells.
We and others reported that certain self-peptides were immunogenic in syngeneic animals (21, 22) . Using mouse self-MHC class I protein as a model antigen, we showed that the self-peptide L d 61-80 elicited the proliferation of CD4 + class II-restricted T cells in syngeneic B10.A mice (H-2a) . This result demonstrated that although the selfpeptide L d 61-80 bound with high affinity to self-class II restriction elements, it failed to reach the threshold of presentation that ensures T cell tolerance during development (21, 23 ) (cryptic self-peptide). Another recent study by Loss et al. indicated that BALB/c (H-2 a) APCs naturally processed and presented the setf-peptide L d 61-80 in vitro in association with MHC class I! molecules (24) . This prompted us to determine whether, in contrast to B10.A mice, continuous presentation of the self-peptide L a 61-80 in BALB/c mice had occurred in vivo during thymic selection and had indeed resulted in tolerance induction of the corresponding autoreactive T cells (dominant self-peptide).
In this article, our aim was to identify the factors that control the selection of the self-peptide L d 61-80 for in vivo presentation to T cells. To address this question, we analyzed the class II-restricted presentation of the self-peptide L a 61-80 to CD4 + autoreactive T cells in different mouse strains. We first showed that crypticity or dominance ofL d 61-80 was not an intrinsic property of this selfpeptide since L d 61-80 was found tolerogenic (dominant) in BALB/c mice while it was immunogenic (cryptic) in B10.A mice. Further immunogenetic analysis revealed that 1Abbreviations used in this paper: din2, BALB/c-dm2; HEL, hen egg white lysozyme; Ii, invariant chain. the self-peptide L d 61-80 was cryptic in different H-2 a mice, but consistendy dominant in mice expressing the H-2 a MHC haplotype, regardless of their background genes. To map the gene that controlled L d 61-80 presentation, we compared the MHC class II presentation of the self-peptide in a panel of H-2 recombinant mouse strains. This led us to identify a 170-kb region of the MHC locus that encodes a factor(s) responsible for differential processing and presentation of the self-L a peptide in MHC class II context.
Materials and Methods
Peptides. The peptides used in this study were synthesized in the Norris Cancer Center Microchemistry Laboratory (USC) with a peptide synthesizer (model 430A; Applied Biosystems, Inc., Foster City, CA) using modified Merrifield chemistry as described (21) . The amino acid sequence of the MHC class I-derived peptide L d 61-80 was EtLITQIAKGQEQWFILVNLR, T. The overlapping MHC class I peptides were synthesized using the pin synthesis technique. The procedure was modified as described in detail elsewhere (25) so that the peptides could be cleaved from the pins.
Mice and Immunizations. The mice used in this study were obtained from The Jackson Laboratory (Bar Harbor, ME) and were housed at UCSF animal facilities. The mutant mouse strain BALB/c-dm2 (dm2) does not express the MHC class I L d protein because of a deletion of the relevant 3' flanking region of the L d gene. B10.GD mice that do not express E d class II MHC molecules were a generous gift from Dr. E. E. Sercarz (University of California at Los Angeles, Los Angeles, CA). Mice of either sex were used at 3-8 mo of age. The mice were immunized in their hind footpads with 20 p,g of the MHC peptide emulsified in complete CFA (Difco Laboratories, Detroit, MI).
Lymph Node and Spleen T Cell Proliferation Assays. Popliteal lymph node and spleen cells were obtained 9-10 d after immunization, and they were used in antigen-induced proliferation assays. Suspensions of 5 X 10 s lymph node and 106 spleen cells were prepared and washed in serum-free HL-1 medium (*Centrex, Portland, ME). The cells were then cultured in either 0.2 ml of ilL-1 medium containing 2 mM glutamine alone, in the presence of the self-MHC class I peptide L d 61-80 (50 ~g/ml), or with a control peptide in 96-welt culture dishes for 4 d. Antigeninduced proliferation was assessed by determining the incorporation of 1 /~Ci [3H]thymidine during the last 18 h of culture.
Immunofluorescence Analyses. Splenocytes and thymocytes from normal mice were collected and washed in Dulbecco's PBS containing 2% FCS and 0.1% sodium azide (Sigma Immunochemicals, St. Louis, MO). The cells (2-5 • 105 cells per tube) were then incubated for 30 rain on ice in the presence of serial concentrations of the FITC-conjugated anti-mouse H-2Ld-reactive mAb, 30-5-7 (26) . In all experiments, cells from Ld-deficient BALB/c-dm2 (dm2) mice were used as a negative control. Nonspecific fluorescence was also measured using an irrelevant isotype-matched FITC-conjugated mouse mAb (IgG2a) (PharMingen, San Diego, CA). Fluorescence analyses were performed on viable nucleated cells using a FACSort | flow cytometer (Becton Dickinson & Co., Mountain View, CA), and the data were displayed as mean channel fluorescence.
T Cell Lines. The CD4 + T cell lines P69.2 (Ea-restricted, L d 61-80-specific) and B10.A-P11.2 (Ek-restricted, L a 61-80--spe-cific) were obtained from BALB/c-dm2 and B10.A mice, respectively. Mice were immunized in their hind footpads with the peptide L d 61-80 (20-50 I~g) emulsified in CFA. 9 d later, pophteal lymph node cells were aseptically collected and cultured (5 X 10 6 cells/ml) in DME (ICN, Costa Mesa, CA) supplemented with 2 mM glutamine, 2 • 10 -5 M 2-ME, 100 U/ml penicillin, 100 p,g/ml streptomycin, and 10% FCS (Gemini Bioproducts, Inc., Calabasas, CA). T cell lines were stimulated every other week with either antigen (peptide at final concentration 20 mM), syngeneic irradiated splenocytes (2 • 106 cells/ml) as feeders, and 10 U/ml of human rlL-2 (Genzyme Corp., Cambridge, MA) or IL-2 alone (25 U/ml). CD4 + phenotype of the T cell lines was shown by two-color fluorescence analysis using anti-CD4-FITC (RM4-4) and anti-CD8-PE (53.6.7) mAb conjugates (PharMingen). The prohferation of the T cell line B10.A-P11.2 to the peptide L a 61-80 was found to be inhibited by anti-E k (17-3-3S), but not anti-A k (10. (27) .
Results

The Cryptic Phenotype Is Not an Intrinsic Property of the SelfPeptide L d 61-80.
We have previously shown that the self-MHC class I peptide L d 61-80 induced potent MHC class II-restricted T cell responses in syngeneic B10.A mice. This self-peptide was cryptic in that despite its high binding affinity for self-MHC class II molecules, it had not been presented efficiently enough to ensure tolerance in the developing thymus of B10.A mice (21) . Also, recent work by Loss et al. suggested that L d 61-80 was regularly presented in vitro at the surface ofBALB/c APCs in association with self-MHC class II molecules (24) . Here, we observed that in contrast to B10.A mice ( Fig. 1 A) , the pep-
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tide L a 61-80 was nonimmunogenic in BALB/c mice ( Fig.  1 B) , suggesting that continuous presentation of the selfpeptide in BALB/c mice in vivo had resulted in deletion/ inactivation of the corresponding autoreactive T cells. We compared the immunogenicity of the self-MHC class I peptide L d 61-80 in mouse strains differing either by their background or MHC genes. As shown in Table 1 shown by its capacity to competitively inhibit the response of the Ea-restricted T cell hybridoma 1E1 to its specific peptide, k repressor 12-26 ( Fig. 2 B) . Furthermore, the peptide L a 61-80 bound equally well to E k class II molecules ( Fig. 2 A) , showing that differential binding to E d and E k was not responsible for L a 61-80 phenotype.
We 
MHC Locus of H-2 a Mice Encodes a Factor That Prevents the Presentation of the L d 61-80
Peptide. The Ea-restricted CD4 + T cell line P69.2 (dm2 anti-L d 61-80) was shown to proliferate and secrete IL-2 when incubated with BALB/c APCs in the absence of exogenously added peptide (Fig. 3 B) . In contrast, addition ofpeptide L d 61-80 was required to stimulate P69.2 T cell line in the presence of din2 APCs. Similar in vitro studies were conducted on the B10.A-derived B10.A-P11.2 CD4 + T cell line, which recognizes L a 61-80 peptide associated with E k MHC class II molecules. As shown in Fig. 3 A, In vitro studies have revealed that, in contrast to the pa- Fig. 4 , dm2 lymph node T cells responded to a series of five consecutive peptides describing a determinant whose core region was 69-76. We conclude that after immunization of B10.A and din2 mice with the self-peptide L d 61-80, both H-2 k and H-2 a class II-restricted T cell responses were directed to a similar determinant on the self-peptide.
The Self-Antigen L a Is Expressed at Similar Levels in Tolerant
and Nontolerant Mice. Several reports indicate that the extent ofT cell tolerance to self-determinants often correlates with quantitative expression of the self-protein (28, 29) . To test this possibility, we compared the quantity of L d ex- 
Mapping of the M H C Locus Region That Controls the MHC Class II-restricted Presentation of the Self-Peptide L a 61-80.
To identify the region of the M H C locus that contains the gene(s) involved in the processing and presentation of the self-peptide L d 61-80, we analyzed the T cell response to this peptide in a series of H-2 recombinant strains. As shown in Table 2 whose sequence is identical to L a for residues 61-80. L a 61-80 self-peptide was found immunogenic in B10.AKM mice ( Table 2) . Nontolerant B10.A and B10.AKM mice differ from tolerant B10.D2 mice in the portion o f the H-2 region that is centromeric to the D gene, suggesting that the M H C gene(s) that govern(s) self-peptide L a 61-80 processing is located in this region (Table 2) . O n the other hand, the L a 61-80 self-peptide was cryptic in A.TL and B10.MBR, mice while it was dominant in the parental H-2 s and H-2 b mice. Although unlikely, the absence o f E molecules could have contributed to the nonresponder phenotype in the parental strains. A.TL and B 1 0 . M B R mice differ from A/J and B10.AKM mice, respectively, at the H-2 K locus (Table 2) We conclude that the gene(s) responsible for the phenotype of the peptide L d 61-80 must reside centromeric of the E~3 gene and telomeric of the K locus. Furthermore, the observation that L d 61-80 was dominant in B10.A(5P,.) and cryptic in B10.MBR allowed us to refine the mapping of the gene(s) controlling L a processing to a region of N170 kb delimited by the intrarecombinational points in these two mouse strains (Fig. 8) .
-1-2 Region Gene(s) That Control(s) the Presentation of L a 61-80
Strain H-2 K A E L D Medium L d 61-80 BALB/c d d d d d d 2,
Discussion
Recent studies have revealed that certain self-peptides (cryptic self) do not reach the threshold of presentation that ensures tolerance induction o f developing T cells (21, 22) . Meanwhile, there is increasing evidence that circumstances which lead to the presentation of cryptic self-determinants in adults result in the initiation of an autoimmune process (27, 31, 32) . It is therefore crucial to determine which factors control the in vivo processing and presentation of self-antigens. In this paper, the self-MHC class I peptide L a 61-80 was used as a model antigen to elucidate the mechanisms that govern the presentation in vivo of self-peptides for T cell tolerance induction.
The self-peptide L d 61-80 was previously reported to be immunogenic in syngeneic B10.A mice while here we observed that it could not induce any in vivo T cell responses in BALB/c mice. We have accumulated much evidence that associates lack of tolerance in B10.A mice to L d 61-80 with poor or incomplete processing of this self-peptide. In this report we show that, in contrast to B10.A APCs, the self-peptide L a 61-80 was naturally processed and continuously presented in association with M H C class II by BALB/c APCs; a phenomenon that ensured the deletion/inactivation of L d 61-80-reactive T cells during development. Therefore, the cryptic phenotype of L d 61-80 we previously reported in B10.A mice does not represent an intrinsic property of this self-peptide as it is dominant in another mouse strain, BALB/c.
The quantity o f self-protein available for presentation to autoimmune T cells plays a critical role in the process of tolerance induction to self-determinants present on this protein (28, 29) . Here, we showed that APCs derived from tolerant and nontolerant mouse strains expressed similar amounts of the L a self-antigen at both n~N A and protein levels. Analyses of the autologous peptides bound to M H C molecules, as well as determination o f the molecular and cellular events involved in antigen processing, have begun to shed light on the mechanisms by which determinants on self-protein are selected for presentation to T cells. Recent studies using genetically engineered antigen processing-deficient mice showed the contribution of different processing cofactors to antigen presentation in vivo and suggested their involvement in the acquisition of T cell repertoire during development (34, 35) . However, it remains unclear whether allelic polymorphism of the M H C genes encoding these processing cofactors influences the selection of the T cell repertoire of normal mice. Here, we observed that tolerogenicity or immunogenicity of the self-peptide L a 61-80 was a result of differential processing of the self-L d protein in different mouse strains. This finding gave us a unique opportunity to investigate the contribution of antigen processing to in vivo T cell tolerance induction in normal mice.
The MHC class II-restricted presentation ofL d 61-80 peptide from internally synthesized L a protein segregates from both exogenous and endogenous presentation pathways (24) . We therefore hypothesized that either class I or class II processing-associated cofactors could play a role in this "nonclassical" antigen processing pathway. Here, we showed that class II presentation of the self-peptide L a 61-80 for tolerance induction of corresponding CD4 + autoreactive T cells was controlled by gene(s) which maps to a 170-kb portion of the class II region of the MHC locus. Ma and Mb genes located in this class II region of MHC locus have recently been shown to play an important role in class IIrestricted processing. H-2M molecules presumably promote antigen presentation by "freeing" MHC class II peptide-binding grooves from Ii peptides in the endosomes thus allowing the binding of other antigen peptides to MHC class II molecules (17, 18) . Alternatively, the factor(s) involved in L d 61-80 processing mediates its function by disrupting the presentation of the peptide. H-2M molecules and the L a 61-80 processing-associated factor, therefore, seem to be distinct. Another molecule, the Ii, also contributes to the selection of class II-restricted peptides by targeting class II molecules to selected endosomal subcompartments (15) . However, Ii is encoded outside the MHC locus, and a class II-restricted L a 61-80-specific T cell hybridoma could be stimulated in the presence of both Iipositive and -negative APCs (24) . We conclude that Ii does not control the presentation of the L a peptide.
Among the genes associated with MHC class I processing, TAP genes are unhkely to be responsible for the phenotype ofL d 61-80. First, L d 61-80 presentation by class II molecules does not require a functional TAP-1 protein (24) . Second, although limited allehc polymorphism in the mouse transporter genes has been found, it does not seem to have a major impact on the selection of the pool of peptides available for presentation (36, 37) . Alternatively, the LMP-7 subunit of the proteasome, despite its documented involvement in the class I processing pathway, could represent a possible candidate for regulating the presentation of L d 61-80. Supporting this view, H-2 k and H-2 a mice express different LMP-7 alleles (38, 39) . The LMP-7 allelic form expressed by H-2 a, but not H-2 d mice, by cleaving the L d molecule at a particular site could destroy the L d 61-80 determinant and therefore prevent its presentation in MHC class II context to autoreactive thymic T cells. Work to address this possibility is in progress in our laboratory.
The lack of spontaneous presentation of the self-peptide L a 61-80 in H-2 a, but not H-2 a, mice results in incomplete tolerance induction of corresponding autoreactive T cells. Our results show that a factor encoded within a 170-kb portion of the H-2 a, but not H-2 a, MHC locus prevents the presentation of the self-peptide L a 61-80. This factor presumably mediates its function by disrupting the processing of the antigen peptide. It is possible that this processing factor cleaves L a protein within the sequence 61-80 thus destroying the determinant. Another alternative is that this factor cleaves L a protein outside the sequence 61-80. This would create another determinant that cannot bind to MHC class II molecules or that could trigger another set of T cells. Finally, this factor could mediate its effect by binding L a 61-80 peptide, thus preventing its association with E k MHC class II restriction elements. It is important to note that B10.A APCs do not apparently have a major defect in antigen processing since they can present a large variety of endogenously and exogenously processed peptides of self-and foreign origin at their surface. Allelic variation of processing factors may control the selection of certain of self-peptides thus contributing to the acquisition of the T cell repertoire in a given strain.
In conclusion, we have shown that while tolerance induction of CD4 + T cells is generally attributed to exogenous processing and presentation of circulating self-proteins, endogenously processed self-peptides presented in association with MHC class II molecules also contribute to the selection of developing CD4 + T cells in the thymus. In addition, we observed that MHC class II-restricted presentation of the endogenously processed self-peptide L a 61-80 for T cell tolerance induction is controlled by a factor encoded within a 170-kb portion of the class II region of the MHC locus. Apparently, this factor mediates its function by preventing the presentation of the self-peptide in H-2 a but not H-2 a mice and therefore seems to segregate from previously described antigen processing cofactors. This suggests that allelic polymorphism in antigen processing cofactor genes, by contributing to the selection of self-peptides available for presentation by self-MHC molecules, may play an essential role in tolerance induction and acquisition of the T cell repertoire during ontogeny. Therefore, identification of the antigen processing factors and elucidation of their functions may be crucial for understanding genetic susceptibility to certain autoimmune diseases and the mechanisms that initiate self-reactive T cell responses.
